Ownership history in MORGAN STANLEY · 8 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in TOURMALINE BIO INC (TRML). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 252,093 | -110,643 | -30.5% | 0.00% | $12.1M | — |
| 2025 Q2 | ADDED | 362,736 | +76,991 | +26.9% | 0.00% | $5.8M | — |
| 2025 Q1 | ADDED | 285,745 | +81,463 | +39.9% | 0.00% | $4.3M | — |
| 2024 Q4 | REDUCED | 204,282 | -33,467 | -14.1% | 0.00% | $4.1M | — |
| 2024 Q3 | REDUCED | 237,749 | -90,193 | -27.5% | 0.00% | $6.1M | — |
| 2024 Q2 | ADDED | 327,942 | +311,623 | +1909.6% | 0.00% | $4.2M | — |
| 2024 Q1 | ADDED | 16,319 | +10,145 | +164.3% | 0.00% | $374K | — |
| 2023 Q4 | INITIATED | 6,174 | — | — | 0.00% | $162K | — |
As of 2025 Q3 — sorted by position size